Diabetes Clinical Trials

Showing 2561-2580 of 7,874 trials

ForgIng New Paths to Prevent DIabeTes (FINDIT)

NCT02747108

This study will evaluate the effects of screening for type 2 diabetes mellitus (T2DM) and brief counseling about screening test results on weight and key health behaviors among Veterans with risk factors for T2DM. Study participants will be randomly assigned to one of two study groups: (1) Blood Test Group or (2) Brochure Group. Participants in the Blood Test Group will complete a blood test called hemoglobin A1c (HbA1c) which measures average blood sugar levels. Participants will receive brief counseling about the results from their primary care provider or someone authorized to speak on their behalf. Participants randomly selected for the Brochure Group will review a handout from the VA National Center for Health Promotion and Disease Prevention (NCP) on recommended screening tests and immunizations. All participants will be asked to complete a survey prior to study group assignment, immediately after a Primary Care appointment, 3 months after enrollment, and 12 months after enrollment.

Prediabetes

VA Office of Research and Development315 participantsStarted Dec 2015

Ann Arbor, Michigan, United States

COMPLETEDPhase 4

Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria

NCT03331289

Research Design/Plan: After screening, each subject will receive 1 measurements of Endogenous Glucose Production \[EGP\] with prime-continuous Infusion of 3-3H-glucose. After completing the EGP measurement each subject will receive a Double Tracer Oral Glucose Tolerance Test \[OGTT\]. Methods: Visit 1: Screening. Medical history will be obtained, physical exam performed, and pregnancy test performed. Visit 2: Endogenous Glucose Production Measurement: The rate of EGP will be measured with 3-3H-glucose. Visit 3: Double Tracer OGTT

Diabetes Mellitus, Type 2

The University of Texas Health Science Center at San Antonio107 participantsStarted Feb 2018

San Antonio, Texas, United States

ForgIng New Paths to Prevent DIabeTes (FINDIT)

Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria

Related Searches

Improving Recruitment and Retention for Diabetes Self-Management Education and Support

Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM

Organisational Models Supported by Technology for the Management of Diabetic Disease and Its Complications in a Diabetic Clinic Setting. A Randomised Controlled Trial Targeting Type 2 Diabetes Individuals With Non-ideal Glycemic Values

A Church Based Intervention to Improve Diabetes Care

To Compare the Pharmacokinetics and Pharmacodynamics of HR20014, INS068 and INS062 After Single Subcutaneous Injection in Healthy Subjects

Development of Ketoacidosis During the Perioperative Period: an Observational Study 'The DKAP Study'

Feasibility of Outpatient Closed Loop Control With the iLet Bionic Pancreas in Cystic Fibrosis Related Diabetes

A Randomized Trial of a BE-EHR Module to Guide the Care of Older Adults With Diabetes

Measurement of Glucose Metabolism in Humans: Effect of Recurrent Hypoglycemia on Hypothalamic GABA

Real Time Continuous Glucose Monitoring System in T2DM With Pregnacy

Berberine on the Secretion of Incretin

Dynamic Parameters of Glucose Control in Relation to Biomarkers in Serum and Intraocular Fluid in Patients With Diabetes

"The Effect of Reiki on Metabolic Parameters in Obese Type 2 Diabetes Patients''

Type 2 Diabetes and Exercise Function in Single Leg Exercises

Topical Insulin in Neurotrophic Keratopathy After Diabetic Vitrectomy

Assessment of Hand Grip Strength Using Jamar Dynamometer

Tissue Changes in Diabetes in Adults and Children Using Multispectral Optoacoustic Tomography.

Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)